These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 20818335)

  • 1. Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio.
    Kuperstein I; Broersen K; Benilova I; Rozenski J; Jonckheere W; Debulpaep M; Vandersteen A; Segers-Nolten I; Van Der Werf K; Subramaniam V; Braeken D; Callewaert G; Bartic C; D'Hooge R; Martins IC; Rousseau F; Schymkowitz J; De Strooper B
    EMBO J; 2010 Oct; 29(19):3408-20. PubMed ID: 20818335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease.
    Ryan TM; Roberts BR; McColl G; Hare DJ; Doble PA; Li QX; Lind M; Roberts AM; Mertens HD; Kirby N; Pham CL; Hinds MG; Adlard PA; Barnham KJ; Curtain CC; Masters CL
    J Neurosci; 2015 Feb; 35(7):2871-84. PubMed ID: 25698727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons.
    Zhang Y; McLaughlin R; Goodyer C; LeBlanc A
    J Cell Biol; 2002 Feb; 156(3):519-29. PubMed ID: 11815632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.
    Jan A; Gokce O; Luthi-Carter R; Lashuel HA
    J Biol Chem; 2008 Oct; 283(42):28176-89. PubMed ID: 18694930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP.
    Klementieva O; Willén K; Martinsson I; Israelsson B; Engdahl A; Cladera J; Uvdal P; Gouras GK
    Nat Commun; 2017 Mar; 8():14726. PubMed ID: 28287086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous in vitro formation of supramolecular beta-amyloid structures, "betaamy balls", by beta-amyloid 1-40 peptide.
    Westlind-Danielsson A; Arnerup G
    Biochemistry; 2001 Dec; 40(49):14736-43. PubMed ID: 11732892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
    Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
    J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
    Weiffert T; Meisl G; Flagmeier P; De S; Dunning CJR; Frohm B; Zetterberg H; Blennow K; Portelius E; Klenerman D; Dobson CM; Knowles TPJ; Linse S
    ACS Chem Neurosci; 2019 May; 10(5):2374-2384. PubMed ID: 30793584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation at Ser
    Hu ZW; Ma MR; Chen YX; Zhao YF; Qiang W; Li YM
    J Biol Chem; 2017 Feb; 292(7):2611-2623. PubMed ID: 28031462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.
    Gu L; Guo Z
    Biochem Biophys Res Commun; 2021 Jan; 534():292-296. PubMed ID: 33272573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid.
    Huang TH; Yang DS; Fraser PE; Chakrabartty A
    J Biol Chem; 2000 Nov; 275(46):36436-40. PubMed ID: 10961999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-β Peptides: Protective Effect of Human Serum Albumin.
    Domínguez-Prieto M; Velasco A; Vega L; Tabernero A; Medina JM
    J Alzheimers Dis; 2017; 55(1):171-182. PubMed ID: 27662292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa.
    Fu Z; Van Nostrand WE; Smith SO
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal peptides coassemble into Abeta42 oligomers and protect neurons against Abeta42-induced neurotoxicity.
    Fradinger EA; Monien BH; Urbanc B; Lomakin A; Tan M; Li H; Spring SM; Condron MM; Cruz L; Xie CW; Benedek GB; Bitan G
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14175-80. PubMed ID: 18779585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species.
    Ziehm T; Brener O; van Groen T; Kadish I; Frenzel D; Tusche M; Kutzsche J; Reiß K; Gremer L; Nagel-Steger L; Willbold D
    ACS Chem Neurosci; 2016 Aug; 7(8):1088-96. PubMed ID: 27240424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of crocin on the amyloid fibril formation of Aβ42 peptide in vitro.
    Ghahghaei A; Bathaie SZ; Kheirkhah H; Bahraminejad E
    Cell Mol Biol Lett; 2013 Sep; 18(3):328-39. PubMed ID: 23737042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells.
    Bharadwaj P; Solomon T; Sahoo BR; Ignasiak K; Gaskin S; Rowles J; Verdile G; Howard MJ; Bond CS; Ramamoorthy A; Martins RN; Newsholme P
    Sci Rep; 2020 Jun; 10(1):10356. PubMed ID: 32587390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
    Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
    ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
    Sharoar MG; Thapa A; Shahnawaz M; Ramasamy VS; Woo ER; Shin SY; Park IS
    J Biomed Sci; 2012 Dec; 19(1):104. PubMed ID: 23259691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.